WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
复制标题
DOI:
10.1158/0008-5472.can-16-0621
复制
发表时间:
2016-10-15
期刊:
影响因子:
11.2
通讯作者:
Aqeilan RI
中科院分区:
文献类型:
--
作者:
Del Mare S;Husanie H;Iancu O;Abu-Odeh M;Evangelou K;Lovat F;Volinia S;Gordon J;Amir G;Stein J;Stein GS;Croce CM;Gorgoulis V;Lian JB;Aqeilan RI
Osteosarcoma (OS) is a highly metastatic form of bone cancer in adolescents and young adults which is resistant to existing treatments. Development of an effective therapy has been hindered by very limited understanding of the mechanisms of osteosarcomagenesis. Here, we used genetically engineered mice to investigate the effects of deleting the tumor suppressor Wwox selectively in either osteoblast progenitors or mature osteoblasts. Mice with conditional deletion of Wwox in pre-osteoblasts (WwoxΔosx1) displayed a severe inhibition of osteogenesis accompanied by p53 upregulation, effects that were not observed in mice lacking Wwox in mature osteoblasts. Deletion of p53 in WwoxΔosx1 mice rescued the osteogenic defect. In addition, the Wwox;p53Δosx1 double knockout mice developed poorly differentiated osteosarcomas that resemble human OS in histology, location, metastatic behavior, and gene expression. Strikingly, the development of osteosarcomas in these mice was greatly accelerated compared to mice lacking p53 only. In contrast, combined WWOX and p53 inactivation in mature osteoblasts did not accelerate osteosarcomagenesis compared to p53 inactivation alone. These findings provide evidence that a WWOX-p53 network regulates normal bone formation and that disruption of this network in osteoprogenitors results in accelerated OS. The Wwox;p53Δosx1 double knockout establishes a new OS model with significant advancement over existing models.